TomasPascualMD
@tomaspascualmd.bsky.social
Looking forward to participating in the @aseica.bsky.social
- ASPIC Meeting, where I’ll be discussing the role of oncolytic viruses in immune activation in breast cancer.
Grateful for the invitation and the opportunity to exchange ideas with such an outstanding scientific community.
- ASPIC Meeting, where I’ll be discussing the role of oncolytic viruses in immune activation in breast cancer.
Grateful for the invitation and the opportunity to exchange ideas with such an outstanding scientific community.
November 9, 2025 at 8:01 PM
Looking forward to participating in the @aseica.bsky.social
- ASPIC Meeting, where I’ll be discussing the role of oncolytic viruses in immune activation in breast cancer.
Grateful for the invitation and the opportunity to exchange ideas with such an outstanding scientific community.
- ASPIC Meeting, where I’ll be discussing the role of oncolytic viruses in immune activation in breast cancer.
Grateful for the invitation and the opportunity to exchange ideas with such an outstanding scientific community.
Reposted by TomasPascualMD
Analysis of residual disease specimens is challenging - but a fascinating study pooling 4 HER2+ clinical trials!
@oncoalert.bsky.social @tomaspascualmd.bsky.social
www.sciencedirect.com/science/arti...
@oncoalert.bsky.social @tomaspascualmd.bsky.social
www.sciencedirect.com/science/arti...
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2+ early breast cancer (EBC)
In HER2+ early breast cancer (EBC), we investigated tumor and immune changes during neoadjuvant treatment and their impact on residual disease (RD) bi…
www.sciencedirect.com
December 21, 2024 at 1:51 PM
Analysis of residual disease specimens is challenging - but a fascinating study pooling 4 HER2+ clinical trials!
@oncoalert.bsky.social @tomaspascualmd.bsky.social
www.sciencedirect.com/science/arti...
@oncoalert.bsky.social @tomaspascualmd.bsky.social
www.sciencedirect.com/science/arti...